uniQure (QURE) Free Cash Flow (2016 - 2026)
uniQure (QURE) recorded quarterly Free Cash Flow of -$38.4 million in Q1 2026, up 50.59% quarter-over-quarter from -$77.7 million in Q4 2025, and up 13.21% on a YoY basis from -$33.9 million in Q1 2025.
uniQure (QURE) Free Cash Flow (2016 - 2026) Analysis & Trends
uniQure's Free Cash Flow history runs 11 years deep, the most recent figure standing at -$38.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 13.21% year-over-year to -$38.4 million; the TTM figure through Mar 2026 stood at -$172.6 million (down 3.08% YoY), while the FY2025 annual figure was -$178.4 million, up 4.13% from the prior year.
- Free Cash Flow was -$38.4 million for Q1 2026 at uniQure, up from -$77.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $37.2 million in Q3 2023 to a low of -$80.6 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$42.3 million across 5 years, with a median of -$44.2 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 170.24% in 2023, then sank 199.37% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$59.7 million in 2022, then gained by 13.67% to -$51.6 million in 2023, then retreated by 2.53% to -$52.9 million in 2024, then tumbled by 46.9% to -$77.7 million in 2025, then soared by 50.59% to -$38.4 million in 2026.
- The last three Free Cash Flow figures came in at -$38.4 million (Q1 2026), -$77.7 million (Q4 2025), and -$16.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -38.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.38 Mn |
| Mar 31, 2026 | -38.38 Mn |
| Dec 31, 2025 | -77.69 Mn |
| Dec 31, 2025 | -77.69 Mn |
| Sep 30, 2025 | -16.33 Mn |
| Sep 30, 2025 | -16.33 Mn |
| Jun 30, 2025 | -40.16 Mn |
| Jun 30, 2025 | -40.16 Mn |
| Mar 31, 2025 | -44.23 Mn |
| Mar 31, 2025 | -44.23 Mn |
| Dec 31, 2024 | -52.88 Mn |
| Dec 31, 2024 | -52.88 Mn |
| Sep 30, 2024 | -36.98 Mn |
| Sep 30, 2024 | -36.98 Mn |
| Jun 30, 2024 | -33.32 Mn |
| Jun 30, 2024 | -33.32 Mn |
| Mar 31, 2024 | -62.92 Mn |
| Mar 31, 2024 | -62.92 Mn |
| Dec 31, 2023 | -51.58 Mn |
| Dec 31, 2023 | -51.58 Mn |